Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25772 | 272 | 31.9 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
1171 | 2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM | 9352 |
25772 | 1 | CLOMETHIAZOLE//CHLORMETHIAZOLE//AR R008055 | 272 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CLOMETHIAZOLE | authKW | 1207481 | 8% | 51% | 21 |
2 | CHLORMETHIAZOLE | authKW | 1025160 | 8% | 42% | 22 |
3 | AR R008055 | authKW | 224524 | 1% | 100% | 2 |
4 | NMZ | authKW | 224524 | 1% | 100% | 2 |
5 | CHLOMETHIAZOLE | authKW | 149681 | 1% | 67% | 2 |
6 | 5 2 F 18 FLUOROETHYL 4 METHYLTHIAZOLE | authKW | 112262 | 0% | 100% | 1 |
7 | 5 HT1A 5 HYDROXYTRYPTAMINE1A RECEPTOR | authKW | 112262 | 0% | 100% | 1 |
8 | 5 HYDROXYTRYPTAMINE MEDIATED BEHAVIOR | authKW | 112262 | 0% | 100% | 1 |
9 | ALZHEIMERS DISEASE MODIFYING APPROACH | authKW | 112262 | 0% | 100% | 1 |
10 | ANAESTHESIA NEUROINTENS CARE | address | 112262 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1907 | 49% | 0% | 133 |
2 | Anesthesiology | 1352 | 14% | 0% | 37 |
3 | Neurosciences | 142 | 15% | 0% | 42 |
4 | Chemistry, Medicinal | 71 | 6% | 0% | 15 |
5 | Psychiatry | 65 | 7% | 0% | 18 |
6 | Cardiac & Cardiovascular System | 44 | 6% | 0% | 17 |
7 | Critical Care Medicine | 25 | 2% | 0% | 6 |
8 | Toxicology | 19 | 3% | 0% | 9 |
9 | Peripheral Vascular Diseases | 15 | 3% | 0% | 8 |
10 | Clinical Neurology | 8 | 4% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANAESTHESIA NEUROINTENS CARE | 112262 | 0% | 100% | 1 |
2 | NEUROL MAUBEUGE | 112262 | 0% | 100% | 1 |
3 | MS RAMAIAH PHARM | 56130 | 0% | 50% | 1 |
4 | PHARMACEUT PRECLIN DEV | 56130 | 0% | 50% | 1 |
5 | PKPD SECT | 37419 | 0% | 33% | 1 |
6 | COMPARAT COGNIT TEAM | 22449 | 1% | 10% | 2 |
7 | DMPKBAC | 14031 | 0% | 13% | 1 |
8 | GRAZING ANIM PROD | 11224 | 0% | 10% | 1 |
9 | RD BOSTON | 8634 | 0% | 8% | 1 |
10 | TOXICOL DEV | 5907 | 0% | 5% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 5487 | 2% | 1% | 6 |
2 | BRITISH JOURNAL OF ANAESTHESIA | 4962 | 7% | 0% | 20 |
3 | NEURODEGENERATION | 2701 | 1% | 1% | 2 |
4 | ACTA PSYCHIATRICA SCANDINAVICA | 2235 | 4% | 0% | 11 |
5 | ADVANCES IN PAIN RESEARCH AND THERAPY | 1600 | 1% | 0% | 3 |
6 | BIOPHARMACEUTICS & DRUG DISPOSITION | 1450 | 2% | 0% | 5 |
7 | JOURNAL OF PHARMACEUTICAL SCIENCES | 1198 | 4% | 0% | 11 |
8 | BRITISH JOURNAL OF PHARMACOLOGY | 897 | 4% | 0% | 12 |
9 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 875 | 3% | 0% | 8 |
10 | ANAESTHESIA AND INTENSIVE CARE | 780 | 2% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLOMETHIAZOLE | 1207481 | 8% | 51% | 21 | Search CLOMETHIAZOLE | Search CLOMETHIAZOLE |
2 | CHLORMETHIAZOLE | 1025160 | 8% | 42% | 22 | Search CHLORMETHIAZOLE | Search CHLORMETHIAZOLE |
3 | AR R008055 | 224524 | 1% | 100% | 2 | Search AR+R008055 | Search AR+R008055 |
4 | NMZ | 224524 | 1% | 100% | 2 | Search NMZ | Search NMZ |
5 | CHLOMETHIAZOLE | 149681 | 1% | 67% | 2 | Search CHLOMETHIAZOLE | Search CHLOMETHIAZOLE |
6 | 5 2 F 18 FLUOROETHYL 4 METHYLTHIAZOLE | 112262 | 0% | 100% | 1 | Search 5+2+F+18+FLUOROETHYL+4+METHYLTHIAZOLE | Search 5+2+F+18+FLUOROETHYL+4+METHYLTHIAZOLE |
7 | 5 HT1A 5 HYDROXYTRYPTAMINE1A RECEPTOR | 112262 | 0% | 100% | 1 | Search 5+HT1A+5+HYDROXYTRYPTAMINE1A+RECEPTOR | Search 5+HT1A+5+HYDROXYTRYPTAMINE1A+RECEPTOR |
8 | 5 HYDROXYTRYPTAMINE MEDIATED BEHAVIOR | 112262 | 0% | 100% | 1 | Search 5+HYDROXYTRYPTAMINE+MEDIATED+BEHAVIOR | Search 5+HYDROXYTRYPTAMINE+MEDIATED+BEHAVIOR |
9 | ALZHEIMERS DISEASE MODIFYING APPROACH | 112262 | 0% | 100% | 1 | Search ALZHEIMERS+DISEASE+MODIFYING+APPROACH | Search ALZHEIMERS+DISEASE+MODIFYING+APPROACH |
10 | AR A008055 | 112262 | 0% | 100% | 1 | Search AR+A008055 | Search AR+A008055 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WILBY, MJ , HUTCHINSON, PJ , (2004) THE PHARMACOLOGY OF CHLORMETHIAZOLE: A POTENTIAL NEUROPROTECTIVE AGENT?.CNS DRUG REVIEWS. VOL. 10. ISSUE 4. P. 281-294 | 33 | 73% | 20 |
2 | VANDEVREDE, L , TAVASSOLI, E , LUO, J , QIN, ZH , YUE, L , PEPPERBERG, DR , THATCHER, GR , (2014) NOVEL ANALOGUES OF CHLORMETHIAZOLE ARE NEUROPROTECTIVE IN FOUR CELLULAR MODELS OF NEURODEGENERATION BY A MECHANISM WITH VARIABLE DEPENDENCE ON GABA(A) RECEPTOR POTENTIATION.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 2. P. 389-402 | 22 | 44% | 6 |
3 | FULTON, B , PARK, GR , (1993) INTRAVENOUS CHLORMETHIAZOLE.BRITISH JOURNAL OF HOSPITAL MEDICINE. VOL. 48. ISSUE 11. P. 742-747 | 21 | 81% | 0 |
4 | LIU, J , WANG, LN , MA, X , JI, XM , (2016) GAMMA AMINOBUTYRIC ACID (GABA) RECEPTOR AGONISTS FOR ACUTE STROKE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 10. P. - | 15 | 48% | 1 |
5 | GREEN, AR , MURRAY, TK , MISRA, A , SNAPE, MF , JONES, JA , CROSS, AJ , (2000) THE METABOLISM OF CLOMETHIAZOLE IN GERBILS AND THE NEUROPROTECTIVE AND SEDATIVE ACTIVITY OF THE METABOLITES.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 129. ISSUE 1. P. 95-100 | 11 | 85% | 5 |
6 | LIU, J , WANG, LN , (2013) GAMMA AMINOBUTYRIC ACID (GABA) RECEPTOR AGONISTS FOR ACUTE STROKE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 13 | 46% | 6 |
7 | LIU, J , WANG, LN , (2014) GAMMA AMINOBUTYRIC ACID (GABA) RECEPTOR AGONISTS FOR ACUTE STROKE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 8. P. - | 13 | 46% | 0 |
8 | QJN, ZH , LUO, J , VANDEVREDE, L , TAVASSOLI, E , FA', M , TEICH, AF , ARANCIO, O , THATCHER, GRJ , (2012) DESIGN AND SYNTHESIS OF NEUROPROTECTIVE METHYLTHIAZOLES AND MODIFICATION AS NO-CHIMERAS FOR NEURODEGENERATIVE THERAPY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 15. P. 6784 -6801 | 22 | 29% | 1 |
9 | UPTON, RN , ZHENG, DA , GRANT, C , MARTINEZ, AM , (2000) DEVELOPMENT AND VALIDATION OF A RECIRCULATORY PHYSIOLOGICAL MODEL OF THE MYOCARDIAL CONCENTRATIONS OF LIGNOCAINE AFTER INTRAVENOUS ADMINISTRATION IN SHEEP.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 52. ISSUE 2. P. 181 -189 | 14 | 54% | 3 |
10 | VILCHEZ, JJ , LAGO, A , BURGUERA, JA , YAYA, R , CASANOVA, V , (1994) CHLORMETHIAZOLE IN THE MANAGEMENT OF THE OPSOCLONUS-MYOCLONUS SYNDROME.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. VOL. 22. ISSUE 1. P. 55-62 | 14 | 67% | 4 |
Classes with closest relation at Level 1 |